Re: Interesting read
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Interesting read
"Sorry I don't know how to make this smaller. Isn't this what Zenith is working on."
???
Koo
New Message
Please
login
to post a reply